U.S. federal trademark · Serial No. 86674607 · Reg. No. 5015829
Pharmaceutical preparation for the treatment of cancer, namely, an anti-cancer virus provided to select members of the public in clinical trials
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.